Fred Moll, the cofounder of $200 billion Intuitive Surgical, has invested in some 15 companies building robots that could ...

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

Medical Microinstruments (MMI) announced today that it won reimbursement for its surgical lymphovenous bypass (LVB) surgery ...

Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

The long-awaited FDA clearance sets up a showdown in the surgical robotics market between Medtronic and Intuitive Surgical.

FDA clears Medtronic robot for urologic surgeries, enabling use in prostatectomy, nephrectomy and cystectomy across select U.S. hospitals.

The new Category III code, CPT 1019T Lymphovenous bypass, including robotic assistance, when performed, per extremity, will become effective in the U.S. on January 1, 2026.

Hugo is about to joust da Vinci. It’s not a battle between Renaissance geniuses. Instead, a commercial fight is brewing between massive medtech companies to control the future of the ...

Dr. Christopher Ellington, a thoracic surgeon at Ascension Sacred Heart, is the only doctor in the Pensacola area performing ...